Overview
Gabor Nyiro practices in Budapest, Hungary. Mr. Nyiro is rated as an Experienced expert by MediFind in the treatment of Hyperaldosteronism. His top areas of expertise are Adrenal Gland Adenoma, Adrenal Cancer, Adrenocortical Carcinoma, and Multiple Endocrine Neoplasia Type 2.
His clinical research consists of co-authoring 32 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Hyperaldosteronism.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Adrenal CancerMr. Nyiro isAdvanced. Learn about Adrenal Cancer.
- Adrenal Gland AdenomaMr. Nyiro isAdvanced. Learn about Adrenal Gland Adenoma.
- Adrenocortical CarcinomaMr. Nyiro isAdvanced. Learn about Adrenocortical Carcinoma.
- Experienced
- Glucocorticoid ResistanceMr. Nyiro isExperienced. Learn about Glucocorticoid Resistance.
- HyperaldosteronismMr. Nyiro isExperienced. Learn about Hyperaldosteronism.
- Idiopathic Short Stature (ISS)Mr. Nyiro isExperienced. Learn about Idiopathic Short Stature (ISS).
- Multiple Endocrine NeoplasiaMr. Nyiro isExperienced. Learn about Multiple Endocrine Neoplasia.
- Multiple Endocrine Neoplasia Type 1Mr. Nyiro isExperienced. Learn about Multiple Endocrine Neoplasia Type 1.
- Multiple Endocrine Neoplasia Type 2Mr. Nyiro isExperienced. Learn about Multiple Endocrine Neoplasia Type 2.